Global Viral Gastroenteritis Drugs Supply, Demand and Key Producers, 2023-2029
The global Viral Gastroenteritis Drugs market size is expected to reach $ 59 million by 2029, rising at a market growth of 3.9% CAGR during the forecast period (2023-2029).
The Viral Gastroenteritis Drugs market is influenced by several trends that are shaping the development and availability of medications for this condition. Viral gastroenteritis, commonly known as the stomach flu, is caused by various viruses and is characterized by symptoms such as diarrhea, vomiting, abdominal pain, and fever.One major trend in the Viral Gastroenteritis Drugs market is the focus on supportive care and symptom management. Currently, there are no specific antiviral drugs available for the treatment of viral gastroenteritis. Therefore, the primary approach is to manage symptoms such as dehydration, nausea, and diarrhea. Oral rehydration solutions, anti-emetic medications, and anti-diarrheal agents are commonly used to alleviate symptoms and improve patient comfort.
This report studies the global Viral Gastroenteritis Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Viral Gastroenteritis Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Viral Gastroenteritis Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Viral Gastroenteritis Drugs total production and demand, 2018-2029, (K Units)
Global Viral Gastroenteritis Drugs total production value, 2018-2029, (USD Million)
Global Viral Gastroenteritis Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Viral Gastroenteritis Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Viral Gastroenteritis Drugs domestic production, consumption, key domestic manufacturers and share
Global Viral Gastroenteritis Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Viral Gastroenteritis Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Viral Gastroenteritis Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Viral Gastroenteritis Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, AbbVie, Bayer AG, Sanofi S.A., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited and EliLilly and Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Viral Gastroenteritis Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Viral Gastroenteritis Drugs Market, By Region:
1. How big is the global Viral Gastroenteritis Drugs market?
2. What is the demand of the global Viral Gastroenteritis Drugs market?
3. What is the year over year growth of the global Viral Gastroenteritis Drugs market?
4. What is the production and production value of the global Viral Gastroenteritis Drugs market?
5. Who are the key producers in the global Viral Gastroenteritis Drugs market?
The Viral Gastroenteritis Drugs market is influenced by several trends that are shaping the development and availability of medications for this condition. Viral gastroenteritis, commonly known as the stomach flu, is caused by various viruses and is characterized by symptoms such as diarrhea, vomiting, abdominal pain, and fever.One major trend in the Viral Gastroenteritis Drugs market is the focus on supportive care and symptom management. Currently, there are no specific antiviral drugs available for the treatment of viral gastroenteritis. Therefore, the primary approach is to manage symptoms such as dehydration, nausea, and diarrhea. Oral rehydration solutions, anti-emetic medications, and anti-diarrheal agents are commonly used to alleviate symptoms and improve patient comfort.
This report studies the global Viral Gastroenteritis Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Viral Gastroenteritis Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Viral Gastroenteritis Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Viral Gastroenteritis Drugs total production and demand, 2018-2029, (K Units)
Global Viral Gastroenteritis Drugs total production value, 2018-2029, (USD Million)
Global Viral Gastroenteritis Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Viral Gastroenteritis Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Viral Gastroenteritis Drugs domestic production, consumption, key domestic manufacturers and share
Global Viral Gastroenteritis Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Viral Gastroenteritis Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Viral Gastroenteritis Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Viral Gastroenteritis Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, AbbVie, Bayer AG, Sanofi S.A., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited and EliLilly and Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Viral Gastroenteritis Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Viral Gastroenteritis Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Antibiotic
- Antacids
- Antikinetic Agent
- Other
- Hospital
- Clinic
- Other
- Pfizer
- AbbVie
- Bayer AG
- Sanofi S.A.
- AstraZeneca Plc.
- Abbott Laboratories
- GlaxoSmithKline Plc.
- Takeda Pharmaceutical Company Limited
- EliLilly and Company
- Amgen Inc
- C.H.Boehringer Sohn AG & Co.KG
- Daiichi Sankyo Company Limited
- Regeneron Pharmaceuticals lInc.
- Mylan N.V.
- Astellas Pharma Inc.
- Fresenius Kabi AG
1. How big is the global Viral Gastroenteritis Drugs market?
2. What is the demand of the global Viral Gastroenteritis Drugs market?
3. What is the year over year growth of the global Viral Gastroenteritis Drugs market?
4. What is the production and production value of the global Viral Gastroenteritis Drugs market?
5. Who are the key producers in the global Viral Gastroenteritis Drugs market?
1 SUPPLY SUMMARY
1.1 Viral Gastroenteritis Drugs Introduction
1.2 World Viral Gastroenteritis Drugs Supply & Forecast
1.2.1 World Viral Gastroenteritis Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Viral Gastroenteritis Drugs Production (2018-2029)
1.2.3 World Viral Gastroenteritis Drugs Pricing Trends (2018-2029)
1.3 World Viral Gastroenteritis Drugs Production by Region (Based on Production Site)
1.3.1 World Viral Gastroenteritis Drugs Production Value by Region (2018-2029)
1.3.2 World Viral Gastroenteritis Drugs Production by Region (2018-2029)
1.3.3 World Viral Gastroenteritis Drugs Average Price by Region (2018-2029)
1.3.4 North America Viral Gastroenteritis Drugs Production (2018-2029)
1.3.5 Europe Viral Gastroenteritis Drugs Production (2018-2029)
1.3.6 China Viral Gastroenteritis Drugs Production (2018-2029)
1.3.7 Japan Viral Gastroenteritis Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Viral Gastroenteritis Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Viral Gastroenteritis Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Viral Gastroenteritis Drugs Demand (2018-2029)
2.2 World Viral Gastroenteritis Drugs Consumption by Region
2.2.1 World Viral Gastroenteritis Drugs Consumption by Region (2018-2023)
2.2.2 World Viral Gastroenteritis Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Viral Gastroenteritis Drugs Consumption (2018-2029)
2.4 China Viral Gastroenteritis Drugs Consumption (2018-2029)
2.5 Europe Viral Gastroenteritis Drugs Consumption (2018-2029)
2.6 Japan Viral Gastroenteritis Drugs Consumption (2018-2029)
2.7 South Korea Viral Gastroenteritis Drugs Consumption (2018-2029)
2.8 ASEAN Viral Gastroenteritis Drugs Consumption (2018-2029)
2.9 India Viral Gastroenteritis Drugs Consumption (2018-2029)
3 WORLD VIRAL GASTROENTERITIS DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Viral Gastroenteritis Drugs Production Value by Manufacturer (2018-2023)
3.2 World Viral Gastroenteritis Drugs Production by Manufacturer (2018-2023)
3.3 World Viral Gastroenteritis Drugs Average Price by Manufacturer (2018-2023)
3.4 Viral Gastroenteritis Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Viral Gastroenteritis Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Viral Gastroenteritis Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Viral Gastroenteritis Drugs in 2022
3.6 Viral Gastroenteritis Drugs Market: Overall Company Footprint Analysis
3.6.1 Viral Gastroenteritis Drugs Market: Region Footprint
3.6.2 Viral Gastroenteritis Drugs Market: Company Product Type Footprint
3.6.3 Viral Gastroenteritis Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Viral Gastroenteritis Drugs Production Value Comparison
4.1.1 United States VS China: Viral Gastroenteritis Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Viral Gastroenteritis Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Viral Gastroenteritis Drugs Production Comparison
4.2.1 United States VS China: Viral Gastroenteritis Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Viral Gastroenteritis Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Viral Gastroenteritis Drugs Consumption Comparison
4.3.1 United States VS China: Viral Gastroenteritis Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Viral Gastroenteritis Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Viral Gastroenteritis Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Viral Gastroenteritis Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Viral Gastroenteritis Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Viral Gastroenteritis Drugs Production (2018-2023)
4.5 China Based Viral Gastroenteritis Drugs Manufacturers and Market Share
4.5.1 China Based Viral Gastroenteritis Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Viral Gastroenteritis Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Viral Gastroenteritis Drugs Production (2018-2023)
4.6 Rest of World Based Viral Gastroenteritis Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Viral Gastroenteritis Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Viral Gastroenteritis Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Viral Gastroenteritis Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Viral Gastroenteritis Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antibiotic
5.2.2 Antacids
5.2.3 Antikinetic Agent
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Viral Gastroenteritis Drugs Production by Type (2018-2029)
5.3.2 World Viral Gastroenteritis Drugs Production Value by Type (2018-2029)
5.3.3 World Viral Gastroenteritis Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Viral Gastroenteritis Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Viral Gastroenteritis Drugs Production by Application (2018-2029)
6.3.2 World Viral Gastroenteritis Drugs Production Value by Application (2018-2029)
6.3.3 World Viral Gastroenteritis Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Viral Gastroenteritis Drugs Product and Services
7.1.4 Pfizer Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 AbbVie
7.2.1 AbbVie Details
7.2.2 AbbVie Major Business
7.2.3 AbbVie Viral Gastroenteritis Drugs Product and Services
7.2.4 AbbVie Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AbbVie Recent Developments/Updates
7.2.6 AbbVie Competitive Strengths & Weaknesses
7.3 Bayer AG
7.3.1 Bayer AG Details
7.3.2 Bayer AG Major Business
7.3.3 Bayer AG Viral Gastroenteritis Drugs Product and Services
7.3.4 Bayer AG Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Bayer AG Recent Developments/Updates
7.3.6 Bayer AG Competitive Strengths & Weaknesses
7.4 Sanofi S.A.
7.4.1 Sanofi S.A. Details
7.4.2 Sanofi S.A. Major Business
7.4.3 Sanofi S.A. Viral Gastroenteritis Drugs Product and Services
7.4.4 Sanofi S.A. Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi S.A. Recent Developments/Updates
7.4.6 Sanofi S.A. Competitive Strengths & Weaknesses
7.5 AstraZeneca Plc.
7.5.1 AstraZeneca Plc. Details
7.5.2 AstraZeneca Plc. Major Business
7.5.3 AstraZeneca Plc. Viral Gastroenteritis Drugs Product and Services
7.5.4 AstraZeneca Plc. Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 AstraZeneca Plc. Recent Developments/Updates
7.5.6 AstraZeneca Plc. Competitive Strengths & Weaknesses
7.6 Abbott Laboratories
7.6.1 Abbott Laboratories Details
7.6.2 Abbott Laboratories Major Business
7.6.3 Abbott Laboratories Viral Gastroenteritis Drugs Product and Services
7.6.4 Abbott Laboratories Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Abbott Laboratories Recent Developments/Updates
7.6.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.7 GlaxoSmithKline Plc.
7.7.1 GlaxoSmithKline Plc. Details
7.7.2 GlaxoSmithKline Plc. Major Business
7.7.3 GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Product and Services
7.7.4 GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 GlaxoSmithKline Plc. Recent Developments/Updates
7.7.6 GlaxoSmithKline Plc. Competitive Strengths & Weaknesses
7.8 Takeda Pharmaceutical Company Limited
7.8.1 Takeda Pharmaceutical Company Limited Details
7.8.2 Takeda Pharmaceutical Company Limited Major Business
7.8.3 Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Product and Services
7.8.4 Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
7.8.6 Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
7.9 EliLilly and Company
7.9.1 EliLilly and Company Details
7.9.2 EliLilly and Company Major Business
7.9.3 EliLilly and Company Viral Gastroenteritis Drugs Product and Services
7.9.4 EliLilly and Company Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 EliLilly and Company Recent Developments/Updates
7.9.6 EliLilly and Company Competitive Strengths & Weaknesses
7.10 Amgen Inc
7.10.1 Amgen Inc Details
7.10.2 Amgen Inc Major Business
7.10.3 Amgen Inc Viral Gastroenteritis Drugs Product and Services
7.10.4 Amgen Inc Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Amgen Inc Recent Developments/Updates
7.10.6 Amgen Inc Competitive Strengths & Weaknesses
7.11 C.H.Boehringer Sohn AG & Co.KG
7.11.1 C.H.Boehringer Sohn AG & Co.KG Details
7.11.2 C.H.Boehringer Sohn AG & Co.KG Major Business
7.11.3 C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Product and Services
7.11.4 C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 C.H.Boehringer Sohn AG & Co.KG Recent Developments/Updates
7.11.6 C.H.Boehringer Sohn AG & Co.KG Competitive Strengths & Weaknesses
7.12 Daiichi Sankyo Company Limited
7.12.1 Daiichi Sankyo Company Limited Details
7.12.2 Daiichi Sankyo Company Limited Major Business
7.12.3 Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Product and Services
7.12.4 Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Daiichi Sankyo Company Limited Recent Developments/Updates
7.12.6 Daiichi Sankyo Company Limited Competitive Strengths & Weaknesses
7.13 Regeneron Pharmaceuticals lInc.
7.13.1 Regeneron Pharmaceuticals lInc. Details
7.13.2 Regeneron Pharmaceuticals lInc. Major Business
7.13.3 Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Product and Services
7.13.4 Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Regeneron Pharmaceuticals lInc. Recent Developments/Updates
7.13.6 Regeneron Pharmaceuticals lInc. Competitive Strengths & Weaknesses
7.14 Mylan N.V.
7.14.1 Mylan N.V. Details
7.14.2 Mylan N.V. Major Business
7.14.3 Mylan N.V. Viral Gastroenteritis Drugs Product and Services
7.14.4 Mylan N.V. Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Mylan N.V. Recent Developments/Updates
7.14.6 Mylan N.V. Competitive Strengths & Weaknesses
7.15 Astellas Pharma Inc.
7.15.1 Astellas Pharma Inc. Details
7.15.2 Astellas Pharma Inc. Major Business
7.15.3 Astellas Pharma Inc. Viral Gastroenteritis Drugs Product and Services
7.15.4 Astellas Pharma Inc. Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Astellas Pharma Inc. Recent Developments/Updates
7.15.6 Astellas Pharma Inc. Competitive Strengths & Weaknesses
7.16 Fresenius Kabi AG
7.16.1 Fresenius Kabi AG Details
7.16.2 Fresenius Kabi AG Major Business
7.16.3 Fresenius Kabi AG Viral Gastroenteritis Drugs Product and Services
7.16.4 Fresenius Kabi AG Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Fresenius Kabi AG Recent Developments/Updates
7.16.6 Fresenius Kabi AG Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Viral Gastroenteritis Drugs Industry Chain
8.2 Viral Gastroenteritis Drugs Upstream Analysis
8.2.1 Viral Gastroenteritis Drugs Core Raw Materials
8.2.2 Main Manufacturers of Viral Gastroenteritis Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Viral Gastroenteritis Drugs Production Mode
8.6 Viral Gastroenteritis Drugs Procurement Model
8.7 Viral Gastroenteritis Drugs Industry Sales Model and Sales Channels
8.7.1 Viral Gastroenteritis Drugs Sales Model
8.7.2 Viral Gastroenteritis Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Viral Gastroenteritis Drugs Introduction
1.2 World Viral Gastroenteritis Drugs Supply & Forecast
1.2.1 World Viral Gastroenteritis Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Viral Gastroenteritis Drugs Production (2018-2029)
1.2.3 World Viral Gastroenteritis Drugs Pricing Trends (2018-2029)
1.3 World Viral Gastroenteritis Drugs Production by Region (Based on Production Site)
1.3.1 World Viral Gastroenteritis Drugs Production Value by Region (2018-2029)
1.3.2 World Viral Gastroenteritis Drugs Production by Region (2018-2029)
1.3.3 World Viral Gastroenteritis Drugs Average Price by Region (2018-2029)
1.3.4 North America Viral Gastroenteritis Drugs Production (2018-2029)
1.3.5 Europe Viral Gastroenteritis Drugs Production (2018-2029)
1.3.6 China Viral Gastroenteritis Drugs Production (2018-2029)
1.3.7 Japan Viral Gastroenteritis Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Viral Gastroenteritis Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Viral Gastroenteritis Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Viral Gastroenteritis Drugs Demand (2018-2029)
2.2 World Viral Gastroenteritis Drugs Consumption by Region
2.2.1 World Viral Gastroenteritis Drugs Consumption by Region (2018-2023)
2.2.2 World Viral Gastroenteritis Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Viral Gastroenteritis Drugs Consumption (2018-2029)
2.4 China Viral Gastroenteritis Drugs Consumption (2018-2029)
2.5 Europe Viral Gastroenteritis Drugs Consumption (2018-2029)
2.6 Japan Viral Gastroenteritis Drugs Consumption (2018-2029)
2.7 South Korea Viral Gastroenteritis Drugs Consumption (2018-2029)
2.8 ASEAN Viral Gastroenteritis Drugs Consumption (2018-2029)
2.9 India Viral Gastroenteritis Drugs Consumption (2018-2029)
3 WORLD VIRAL GASTROENTERITIS DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Viral Gastroenteritis Drugs Production Value by Manufacturer (2018-2023)
3.2 World Viral Gastroenteritis Drugs Production by Manufacturer (2018-2023)
3.3 World Viral Gastroenteritis Drugs Average Price by Manufacturer (2018-2023)
3.4 Viral Gastroenteritis Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Viral Gastroenteritis Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Viral Gastroenteritis Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Viral Gastroenteritis Drugs in 2022
3.6 Viral Gastroenteritis Drugs Market: Overall Company Footprint Analysis
3.6.1 Viral Gastroenteritis Drugs Market: Region Footprint
3.6.2 Viral Gastroenteritis Drugs Market: Company Product Type Footprint
3.6.3 Viral Gastroenteritis Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Viral Gastroenteritis Drugs Production Value Comparison
4.1.1 United States VS China: Viral Gastroenteritis Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Viral Gastroenteritis Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Viral Gastroenteritis Drugs Production Comparison
4.2.1 United States VS China: Viral Gastroenteritis Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Viral Gastroenteritis Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Viral Gastroenteritis Drugs Consumption Comparison
4.3.1 United States VS China: Viral Gastroenteritis Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Viral Gastroenteritis Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Viral Gastroenteritis Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Viral Gastroenteritis Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Viral Gastroenteritis Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Viral Gastroenteritis Drugs Production (2018-2023)
4.5 China Based Viral Gastroenteritis Drugs Manufacturers and Market Share
4.5.1 China Based Viral Gastroenteritis Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Viral Gastroenteritis Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Viral Gastroenteritis Drugs Production (2018-2023)
4.6 Rest of World Based Viral Gastroenteritis Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Viral Gastroenteritis Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Viral Gastroenteritis Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Viral Gastroenteritis Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Viral Gastroenteritis Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antibiotic
5.2.2 Antacids
5.2.3 Antikinetic Agent
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Viral Gastroenteritis Drugs Production by Type (2018-2029)
5.3.2 World Viral Gastroenteritis Drugs Production Value by Type (2018-2029)
5.3.3 World Viral Gastroenteritis Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Viral Gastroenteritis Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Viral Gastroenteritis Drugs Production by Application (2018-2029)
6.3.2 World Viral Gastroenteritis Drugs Production Value by Application (2018-2029)
6.3.3 World Viral Gastroenteritis Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Viral Gastroenteritis Drugs Product and Services
7.1.4 Pfizer Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 AbbVie
7.2.1 AbbVie Details
7.2.2 AbbVie Major Business
7.2.3 AbbVie Viral Gastroenteritis Drugs Product and Services
7.2.4 AbbVie Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AbbVie Recent Developments/Updates
7.2.6 AbbVie Competitive Strengths & Weaknesses
7.3 Bayer AG
7.3.1 Bayer AG Details
7.3.2 Bayer AG Major Business
7.3.3 Bayer AG Viral Gastroenteritis Drugs Product and Services
7.3.4 Bayer AG Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Bayer AG Recent Developments/Updates
7.3.6 Bayer AG Competitive Strengths & Weaknesses
7.4 Sanofi S.A.
7.4.1 Sanofi S.A. Details
7.4.2 Sanofi S.A. Major Business
7.4.3 Sanofi S.A. Viral Gastroenteritis Drugs Product and Services
7.4.4 Sanofi S.A. Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi S.A. Recent Developments/Updates
7.4.6 Sanofi S.A. Competitive Strengths & Weaknesses
7.5 AstraZeneca Plc.
7.5.1 AstraZeneca Plc. Details
7.5.2 AstraZeneca Plc. Major Business
7.5.3 AstraZeneca Plc. Viral Gastroenteritis Drugs Product and Services
7.5.4 AstraZeneca Plc. Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 AstraZeneca Plc. Recent Developments/Updates
7.5.6 AstraZeneca Plc. Competitive Strengths & Weaknesses
7.6 Abbott Laboratories
7.6.1 Abbott Laboratories Details
7.6.2 Abbott Laboratories Major Business
7.6.3 Abbott Laboratories Viral Gastroenteritis Drugs Product and Services
7.6.4 Abbott Laboratories Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Abbott Laboratories Recent Developments/Updates
7.6.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.7 GlaxoSmithKline Plc.
7.7.1 GlaxoSmithKline Plc. Details
7.7.2 GlaxoSmithKline Plc. Major Business
7.7.3 GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Product and Services
7.7.4 GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 GlaxoSmithKline Plc. Recent Developments/Updates
7.7.6 GlaxoSmithKline Plc. Competitive Strengths & Weaknesses
7.8 Takeda Pharmaceutical Company Limited
7.8.1 Takeda Pharmaceutical Company Limited Details
7.8.2 Takeda Pharmaceutical Company Limited Major Business
7.8.3 Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Product and Services
7.8.4 Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
7.8.6 Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
7.9 EliLilly and Company
7.9.1 EliLilly and Company Details
7.9.2 EliLilly and Company Major Business
7.9.3 EliLilly and Company Viral Gastroenteritis Drugs Product and Services
7.9.4 EliLilly and Company Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 EliLilly and Company Recent Developments/Updates
7.9.6 EliLilly and Company Competitive Strengths & Weaknesses
7.10 Amgen Inc
7.10.1 Amgen Inc Details
7.10.2 Amgen Inc Major Business
7.10.3 Amgen Inc Viral Gastroenteritis Drugs Product and Services
7.10.4 Amgen Inc Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Amgen Inc Recent Developments/Updates
7.10.6 Amgen Inc Competitive Strengths & Weaknesses
7.11 C.H.Boehringer Sohn AG & Co.KG
7.11.1 C.H.Boehringer Sohn AG & Co.KG Details
7.11.2 C.H.Boehringer Sohn AG & Co.KG Major Business
7.11.3 C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Product and Services
7.11.4 C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 C.H.Boehringer Sohn AG & Co.KG Recent Developments/Updates
7.11.6 C.H.Boehringer Sohn AG & Co.KG Competitive Strengths & Weaknesses
7.12 Daiichi Sankyo Company Limited
7.12.1 Daiichi Sankyo Company Limited Details
7.12.2 Daiichi Sankyo Company Limited Major Business
7.12.3 Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Product and Services
7.12.4 Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Daiichi Sankyo Company Limited Recent Developments/Updates
7.12.6 Daiichi Sankyo Company Limited Competitive Strengths & Weaknesses
7.13 Regeneron Pharmaceuticals lInc.
7.13.1 Regeneron Pharmaceuticals lInc. Details
7.13.2 Regeneron Pharmaceuticals lInc. Major Business
7.13.3 Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Product and Services
7.13.4 Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Regeneron Pharmaceuticals lInc. Recent Developments/Updates
7.13.6 Regeneron Pharmaceuticals lInc. Competitive Strengths & Weaknesses
7.14 Mylan N.V.
7.14.1 Mylan N.V. Details
7.14.2 Mylan N.V. Major Business
7.14.3 Mylan N.V. Viral Gastroenteritis Drugs Product and Services
7.14.4 Mylan N.V. Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Mylan N.V. Recent Developments/Updates
7.14.6 Mylan N.V. Competitive Strengths & Weaknesses
7.15 Astellas Pharma Inc.
7.15.1 Astellas Pharma Inc. Details
7.15.2 Astellas Pharma Inc. Major Business
7.15.3 Astellas Pharma Inc. Viral Gastroenteritis Drugs Product and Services
7.15.4 Astellas Pharma Inc. Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Astellas Pharma Inc. Recent Developments/Updates
7.15.6 Astellas Pharma Inc. Competitive Strengths & Weaknesses
7.16 Fresenius Kabi AG
7.16.1 Fresenius Kabi AG Details
7.16.2 Fresenius Kabi AG Major Business
7.16.3 Fresenius Kabi AG Viral Gastroenteritis Drugs Product and Services
7.16.4 Fresenius Kabi AG Viral Gastroenteritis Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Fresenius Kabi AG Recent Developments/Updates
7.16.6 Fresenius Kabi AG Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Viral Gastroenteritis Drugs Industry Chain
8.2 Viral Gastroenteritis Drugs Upstream Analysis
8.2.1 Viral Gastroenteritis Drugs Core Raw Materials
8.2.2 Main Manufacturers of Viral Gastroenteritis Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Viral Gastroenteritis Drugs Production Mode
8.6 Viral Gastroenteritis Drugs Procurement Model
8.7 Viral Gastroenteritis Drugs Industry Sales Model and Sales Channels
8.7.1 Viral Gastroenteritis Drugs Sales Model
8.7.2 Viral Gastroenteritis Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Viral Gastroenteritis Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Viral Gastroenteritis Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Viral Gastroenteritis Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Viral Gastroenteritis Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Viral Gastroenteritis Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Viral Gastroenteritis Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Viral Gastroenteritis Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Viral Gastroenteritis Drugs Production Market Share by Region (2018-2023)
Table 9. World Viral Gastroenteritis Drugs Production Market Share by Region (2024-2029)
Table 10. World Viral Gastroenteritis Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Viral Gastroenteritis Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Viral Gastroenteritis Drugs Major Market Trends
Table 13. World Viral Gastroenteritis Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Viral Gastroenteritis Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Viral Gastroenteritis Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Viral Gastroenteritis Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Viral Gastroenteritis Drugs Producers in 2022
Table 18. World Viral Gastroenteritis Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Viral Gastroenteritis Drugs Producers in 2022
Table 20. World Viral Gastroenteritis Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Viral Gastroenteritis Drugs Company Evaluation Quadrant
Table 22. World Viral Gastroenteritis Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Viral Gastroenteritis Drugs Production Site of Key Manufacturer
Table 24. Viral Gastroenteritis Drugs Market: Company Product Type Footprint
Table 25. Viral Gastroenteritis Drugs Market: Company Product Application Footprint
Table 26. Viral Gastroenteritis Drugs Competitive Factors
Table 27. Viral Gastroenteritis Drugs New Entrant and Capacity Expansion Plans
Table 28. Viral Gastroenteritis Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Viral Gastroenteritis Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Viral Gastroenteritis Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Viral Gastroenteritis Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Viral Gastroenteritis Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Viral Gastroenteritis Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Viral Gastroenteritis Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Viral Gastroenteritis Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Viral Gastroenteritis Drugs Production Market Share (2018-2023)
Table 37. China Based Viral Gastroenteritis Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Viral Gastroenteritis Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Viral Gastroenteritis Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Viral Gastroenteritis Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Viral Gastroenteritis Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Viral Gastroenteritis Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Viral Gastroenteritis Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Viral Gastroenteritis Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Viral Gastroenteritis Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Viral Gastroenteritis Drugs Production Market Share (2018-2023)
Table 47. World Viral Gastroenteritis Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Viral Gastroenteritis Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Viral Gastroenteritis Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Viral Gastroenteritis Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Viral Gastroenteritis Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Viral Gastroenteritis Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Viral Gastroenteritis Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Viral Gastroenteritis Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Viral Gastroenteritis Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Viral Gastroenteritis Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Viral Gastroenteritis Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Viral Gastroenteritis Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Viral Gastroenteritis Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Viral Gastroenteritis Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Viral Gastroenteritis Drugs Product and Services
Table 64. Pfizer Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. AbbVie Basic Information, Manufacturing Base and Competitors
Table 68. AbbVie Major Business
Table 69. AbbVie Viral Gastroenteritis Drugs Product and Services
Table 70. AbbVie Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AbbVie Recent Developments/Updates
Table 72. AbbVie Competitive Strengths & Weaknesses
Table 73. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 74. Bayer AG Major Business
Table 75. Bayer AG Viral Gastroenteritis Drugs Product and Services
Table 76. Bayer AG Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bayer AG Recent Developments/Updates
Table 78. Bayer AG Competitive Strengths & Weaknesses
Table 79. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi S.A. Major Business
Table 81. Sanofi S.A. Viral Gastroenteritis Drugs Product and Services
Table 82. Sanofi S.A. Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Sanofi S.A. Recent Developments/Updates
Table 84. Sanofi S.A. Competitive Strengths & Weaknesses
Table 85. AstraZeneca Plc. Basic Information, Manufacturing Base and Competitors
Table 86. AstraZeneca Plc. Major Business
Table 87. AstraZeneca Plc. Viral Gastroenteritis Drugs Product and Services
Table 88. AstraZeneca Plc. Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. AstraZeneca Plc. Recent Developments/Updates
Table 90. AstraZeneca Plc. Competitive Strengths & Weaknesses
Table 91. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 92. Abbott Laboratories Major Business
Table 93. Abbott Laboratories Viral Gastroenteritis Drugs Product and Services
Table 94. Abbott Laboratories Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Abbott Laboratories Recent Developments/Updates
Table 96. Abbott Laboratories Competitive Strengths & Weaknesses
Table 97. GlaxoSmithKline Plc. Basic Information, Manufacturing Base and Competitors
Table 98. GlaxoSmithKline Plc. Major Business
Table 99. GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Product and Services
Table 100. GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. GlaxoSmithKline Plc. Recent Developments/Updates
Table 102. GlaxoSmithKline Plc. Competitive Strengths & Weaknesses
Table 103. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 104. Takeda Pharmaceutical Company Limited Major Business
Table 105. Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Product and Services
Table 106. Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 108. Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
Table 109. EliLilly and Company Basic Information, Manufacturing Base and Competitors
Table 110. EliLilly and Company Major Business
Table 111. EliLilly and Company Viral Gastroenteritis Drugs Product and Services
Table 112. EliLilly and Company Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. EliLilly and Company Recent Developments/Updates
Table 114. EliLilly and Company Competitive Strengths & Weaknesses
Table 115. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 116. Amgen Inc Major Business
Table 117. Amgen Inc Viral Gastroenteritis Drugs Product and Services
Table 118. Amgen Inc Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Amgen Inc Recent Developments/Updates
Table 120. Amgen Inc Competitive Strengths & Weaknesses
Table 121. C.H.Boehringer Sohn AG & Co.KG Basic Information, Manufacturing Base and Competitors
Table 122. C.H.Boehringer Sohn AG & Co.KG Major Business
Table 123. C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Product and Services
Table 124. C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. C.H.Boehringer Sohn AG & Co.KG Recent Developments/Updates
Table 126. C.H.Boehringer Sohn AG & Co.KG Competitive Strengths & Weaknesses
Table 127. Daiichi Sankyo Company Limited Basic Information, Manufacturing Base and Competitors
Table 128. Daiichi Sankyo Company Limited Major Business
Table 129. Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Product and Services
Table 130. Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Daiichi Sankyo Company Limited Recent Developments/Updates
Table 132. Daiichi Sankyo Company Limited Competitive Strengths & Weaknesses
Table 133. Regeneron Pharmaceuticals lInc. Basic Information, Manufacturing Base and Competitors
Table 134. Regeneron Pharmaceuticals lInc. Major Business
Table 135. Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Product and Services
Table 136. Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Regeneron Pharmaceuticals lInc. Recent Developments/Updates
Table 138. Regeneron Pharmaceuticals lInc. Competitive Strengths & Weaknesses
Table 139. Mylan N.V. Basic Information, Manufacturing Base and Competitors
Table 140. Mylan N.V. Major Business
Table 141. Mylan N.V. Viral Gastroenteritis Drugs Product and Services
Table 142. Mylan N.V. Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Mylan N.V. Recent Developments/Updates
Table 144. Mylan N.V. Competitive Strengths & Weaknesses
Table 145. Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 146. Astellas Pharma Inc. Major Business
Table 147. Astellas Pharma Inc. Viral Gastroenteritis Drugs Product and Services
Table 148. Astellas Pharma Inc. Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Astellas Pharma Inc. Recent Developments/Updates
Table 150. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 151. Fresenius Kabi AG Major Business
Table 152. Fresenius Kabi AG Viral Gastroenteritis Drugs Product and Services
Table 153. Fresenius Kabi AG Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Viral Gastroenteritis Drugs Upstream (Raw Materials)
Table 155. Viral Gastroenteritis Drugs Typical Customers
Table 156. Viral Gastroenteritis Drugs Typical Distributors
List of Figure
Figure 1. Viral Gastroenteritis Drugs Picture
Figure 2. World Viral Gastroenteritis Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Viral Gastroenteritis Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Viral Gastroenteritis Drugs Production (2018-2029) & (K Units)
Figure 5. World Viral Gastroenteritis Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Viral Gastroenteritis Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Viral Gastroenteritis Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Viral Gastroenteritis Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Viral Gastroenteritis Drugs Production (2018-2029) & (K Units)
Figure 10. China Viral Gastroenteritis Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Viral Gastroenteritis Drugs Production (2018-2029) & (K Units)
Figure 12. Viral Gastroenteritis Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Viral Gastroenteritis Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Viral Gastroenteritis Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Viral Gastroenteritis Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Viral Gastroenteritis Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Viral Gastroenteritis Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Viral Gastroenteritis Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Viral Gastroenteritis Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Viral Gastroenteritis Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Viral Gastroenteritis Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Viral Gastroenteritis Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Viral Gastroenteritis Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Viral Gastroenteritis Drugs Markets in 2022
Figure 26. United States VS China: Viral Gastroenteritis Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Viral Gastroenteritis Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Viral Gastroenteritis Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Viral Gastroenteritis Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Viral Gastroenteritis Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Viral Gastroenteritis Drugs Production Market Share 2022
Figure 32. World Viral Gastroenteritis Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Viral Gastroenteritis Drugs Production Value Market Share by Type in 2022
Figure 34. Antibiotic
Figure 35. Antacids
Figure 36. Antikinetic Agent
Figure 37. Other
Figure 38. World Viral Gastroenteritis Drugs Production Market Share by Type (2018-2029)
Figure 39. World Viral Gastroenteritis Drugs Production Value Market Share by Type (2018-2029)
Figure 40. World Viral Gastroenteritis Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Viral Gastroenteritis Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Viral Gastroenteritis Drugs Production Value Market Share by Application in 2022
Figure 43. Hospital
Figure 44. Clinic
Figure 45. Other
Figure 46. World Viral Gastroenteritis Drugs Production Market Share by Application (2018-2029)
Figure 47. World Viral Gastroenteritis Drugs Production Value Market Share by Application (2018-2029)
Figure 48. World Viral Gastroenteritis Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Viral Gastroenteritis Drugs Industry Chain
Figure 50. Viral Gastroenteritis Drugs Procurement Model
Figure 51. Viral Gastroenteritis Drugs Sales Model
Figure 52. Viral Gastroenteritis Drugs Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Table 1. World Viral Gastroenteritis Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Viral Gastroenteritis Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Viral Gastroenteritis Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Viral Gastroenteritis Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Viral Gastroenteritis Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Viral Gastroenteritis Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Viral Gastroenteritis Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Viral Gastroenteritis Drugs Production Market Share by Region (2018-2023)
Table 9. World Viral Gastroenteritis Drugs Production Market Share by Region (2024-2029)
Table 10. World Viral Gastroenteritis Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Viral Gastroenteritis Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Viral Gastroenteritis Drugs Major Market Trends
Table 13. World Viral Gastroenteritis Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Viral Gastroenteritis Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Viral Gastroenteritis Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Viral Gastroenteritis Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Viral Gastroenteritis Drugs Producers in 2022
Table 18. World Viral Gastroenteritis Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Viral Gastroenteritis Drugs Producers in 2022
Table 20. World Viral Gastroenteritis Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Viral Gastroenteritis Drugs Company Evaluation Quadrant
Table 22. World Viral Gastroenteritis Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Viral Gastroenteritis Drugs Production Site of Key Manufacturer
Table 24. Viral Gastroenteritis Drugs Market: Company Product Type Footprint
Table 25. Viral Gastroenteritis Drugs Market: Company Product Application Footprint
Table 26. Viral Gastroenteritis Drugs Competitive Factors
Table 27. Viral Gastroenteritis Drugs New Entrant and Capacity Expansion Plans
Table 28. Viral Gastroenteritis Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Viral Gastroenteritis Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Viral Gastroenteritis Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Viral Gastroenteritis Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Viral Gastroenteritis Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Viral Gastroenteritis Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Viral Gastroenteritis Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Viral Gastroenteritis Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Viral Gastroenteritis Drugs Production Market Share (2018-2023)
Table 37. China Based Viral Gastroenteritis Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Viral Gastroenteritis Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Viral Gastroenteritis Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Viral Gastroenteritis Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Viral Gastroenteritis Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Viral Gastroenteritis Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Viral Gastroenteritis Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Viral Gastroenteritis Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Viral Gastroenteritis Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Viral Gastroenteritis Drugs Production Market Share (2018-2023)
Table 47. World Viral Gastroenteritis Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Viral Gastroenteritis Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Viral Gastroenteritis Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Viral Gastroenteritis Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Viral Gastroenteritis Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Viral Gastroenteritis Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Viral Gastroenteritis Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Viral Gastroenteritis Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Viral Gastroenteritis Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Viral Gastroenteritis Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Viral Gastroenteritis Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Viral Gastroenteritis Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Viral Gastroenteritis Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Viral Gastroenteritis Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Viral Gastroenteritis Drugs Product and Services
Table 64. Pfizer Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. AbbVie Basic Information, Manufacturing Base and Competitors
Table 68. AbbVie Major Business
Table 69. AbbVie Viral Gastroenteritis Drugs Product and Services
Table 70. AbbVie Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AbbVie Recent Developments/Updates
Table 72. AbbVie Competitive Strengths & Weaknesses
Table 73. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 74. Bayer AG Major Business
Table 75. Bayer AG Viral Gastroenteritis Drugs Product and Services
Table 76. Bayer AG Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bayer AG Recent Developments/Updates
Table 78. Bayer AG Competitive Strengths & Weaknesses
Table 79. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi S.A. Major Business
Table 81. Sanofi S.A. Viral Gastroenteritis Drugs Product and Services
Table 82. Sanofi S.A. Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Sanofi S.A. Recent Developments/Updates
Table 84. Sanofi S.A. Competitive Strengths & Weaknesses
Table 85. AstraZeneca Plc. Basic Information, Manufacturing Base and Competitors
Table 86. AstraZeneca Plc. Major Business
Table 87. AstraZeneca Plc. Viral Gastroenteritis Drugs Product and Services
Table 88. AstraZeneca Plc. Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. AstraZeneca Plc. Recent Developments/Updates
Table 90. AstraZeneca Plc. Competitive Strengths & Weaknesses
Table 91. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 92. Abbott Laboratories Major Business
Table 93. Abbott Laboratories Viral Gastroenteritis Drugs Product and Services
Table 94. Abbott Laboratories Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Abbott Laboratories Recent Developments/Updates
Table 96. Abbott Laboratories Competitive Strengths & Weaknesses
Table 97. GlaxoSmithKline Plc. Basic Information, Manufacturing Base and Competitors
Table 98. GlaxoSmithKline Plc. Major Business
Table 99. GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Product and Services
Table 100. GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. GlaxoSmithKline Plc. Recent Developments/Updates
Table 102. GlaxoSmithKline Plc. Competitive Strengths & Weaknesses
Table 103. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 104. Takeda Pharmaceutical Company Limited Major Business
Table 105. Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Product and Services
Table 106. Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 108. Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
Table 109. EliLilly and Company Basic Information, Manufacturing Base and Competitors
Table 110. EliLilly and Company Major Business
Table 111. EliLilly and Company Viral Gastroenteritis Drugs Product and Services
Table 112. EliLilly and Company Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. EliLilly and Company Recent Developments/Updates
Table 114. EliLilly and Company Competitive Strengths & Weaknesses
Table 115. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 116. Amgen Inc Major Business
Table 117. Amgen Inc Viral Gastroenteritis Drugs Product and Services
Table 118. Amgen Inc Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Amgen Inc Recent Developments/Updates
Table 120. Amgen Inc Competitive Strengths & Weaknesses
Table 121. C.H.Boehringer Sohn AG & Co.KG Basic Information, Manufacturing Base and Competitors
Table 122. C.H.Boehringer Sohn AG & Co.KG Major Business
Table 123. C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Product and Services
Table 124. C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. C.H.Boehringer Sohn AG & Co.KG Recent Developments/Updates
Table 126. C.H.Boehringer Sohn AG & Co.KG Competitive Strengths & Weaknesses
Table 127. Daiichi Sankyo Company Limited Basic Information, Manufacturing Base and Competitors
Table 128. Daiichi Sankyo Company Limited Major Business
Table 129. Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Product and Services
Table 130. Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Daiichi Sankyo Company Limited Recent Developments/Updates
Table 132. Daiichi Sankyo Company Limited Competitive Strengths & Weaknesses
Table 133. Regeneron Pharmaceuticals lInc. Basic Information, Manufacturing Base and Competitors
Table 134. Regeneron Pharmaceuticals lInc. Major Business
Table 135. Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Product and Services
Table 136. Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Regeneron Pharmaceuticals lInc. Recent Developments/Updates
Table 138. Regeneron Pharmaceuticals lInc. Competitive Strengths & Weaknesses
Table 139. Mylan N.V. Basic Information, Manufacturing Base and Competitors
Table 140. Mylan N.V. Major Business
Table 141. Mylan N.V. Viral Gastroenteritis Drugs Product and Services
Table 142. Mylan N.V. Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Mylan N.V. Recent Developments/Updates
Table 144. Mylan N.V. Competitive Strengths & Weaknesses
Table 145. Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 146. Astellas Pharma Inc. Major Business
Table 147. Astellas Pharma Inc. Viral Gastroenteritis Drugs Product and Services
Table 148. Astellas Pharma Inc. Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Astellas Pharma Inc. Recent Developments/Updates
Table 150. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 151. Fresenius Kabi AG Major Business
Table 152. Fresenius Kabi AG Viral Gastroenteritis Drugs Product and Services
Table 153. Fresenius Kabi AG Viral Gastroenteritis Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Viral Gastroenteritis Drugs Upstream (Raw Materials)
Table 155. Viral Gastroenteritis Drugs Typical Customers
Table 156. Viral Gastroenteritis Drugs Typical Distributors
List of Figure
Figure 1. Viral Gastroenteritis Drugs Picture
Figure 2. World Viral Gastroenteritis Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Viral Gastroenteritis Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Viral Gastroenteritis Drugs Production (2018-2029) & (K Units)
Figure 5. World Viral Gastroenteritis Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Viral Gastroenteritis Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Viral Gastroenteritis Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Viral Gastroenteritis Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Viral Gastroenteritis Drugs Production (2018-2029) & (K Units)
Figure 10. China Viral Gastroenteritis Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Viral Gastroenteritis Drugs Production (2018-2029) & (K Units)
Figure 12. Viral Gastroenteritis Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Viral Gastroenteritis Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Viral Gastroenteritis Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Viral Gastroenteritis Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Viral Gastroenteritis Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Viral Gastroenteritis Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Viral Gastroenteritis Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Viral Gastroenteritis Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Viral Gastroenteritis Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Viral Gastroenteritis Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Viral Gastroenteritis Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Viral Gastroenteritis Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Viral Gastroenteritis Drugs Markets in 2022
Figure 26. United States VS China: Viral Gastroenteritis Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Viral Gastroenteritis Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Viral Gastroenteritis Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Viral Gastroenteritis Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Viral Gastroenteritis Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Viral Gastroenteritis Drugs Production Market Share 2022
Figure 32. World Viral Gastroenteritis Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Viral Gastroenteritis Drugs Production Value Market Share by Type in 2022
Figure 34. Antibiotic
Figure 35. Antacids
Figure 36. Antikinetic Agent
Figure 37. Other
Figure 38. World Viral Gastroenteritis Drugs Production Market Share by Type (2018-2029)
Figure 39. World Viral Gastroenteritis Drugs Production Value Market Share by Type (2018-2029)
Figure 40. World Viral Gastroenteritis Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Viral Gastroenteritis Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Viral Gastroenteritis Drugs Production Value Market Share by Application in 2022
Figure 43. Hospital
Figure 44. Clinic
Figure 45. Other
Figure 46. World Viral Gastroenteritis Drugs Production Market Share by Application (2018-2029)
Figure 47. World Viral Gastroenteritis Drugs Production Value Market Share by Application (2018-2029)
Figure 48. World Viral Gastroenteritis Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Viral Gastroenteritis Drugs Industry Chain
Figure 50. Viral Gastroenteritis Drugs Procurement Model
Figure 51. Viral Gastroenteritis Drugs Sales Model
Figure 52. Viral Gastroenteritis Drugs Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
